title: Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study.
abstract: Treatment and prevention of pediatric infectious diseases of three commercial probiotic products were evaluated by a double-blind, randomized, controlled trial. Test subjects under age 5, 1062 in total, were distributed randomly into four groups. This investigation showed that L. casei rhamnosus can control bacterial, viral and respiratory infections; a multi-species probiotic reduced gastrointestinal disease significantly. Long-term consumption of L. rhamnosus T cell-1 decreased the incidence of bacterial infection.
authors.affiliation: Department of Pediatrics, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
authors.forename: Jun-Song
authors.initials: JS
authors.lastname: Lin
authors.forename: Yi-Han
authors.initials: YH
authors.lastname: Chiu
authors.forename: Nien-Tsung
authors.initials: NT
authors.lastname: Lin
authors.forename: Chia-Hsiang
authors.initials: CH
authors.lastname: Chu
authors.forename: Kuo-Chin
authors.initials: KC
authors.lastname: Huang
authors.forename: Kuang-Wen
authors.initials: KW
authors.lastname: Liao
authors.forename: Kou-Cheng
authors.initials: KC
authors.lastname: Peng
mesh_terms: D001424:Bacterial Infections / Q000517:prevention & control*; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005759:Gastroenteritis / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D052201:Lacticaseibacillus rhamnosus / Q000276:immunology*; D008297:Male; D019936:Probiotics / Q000494:pharmacology*; D012141:Respiratory Tract Infections / Q000517:prevention & control; D014777:Virus Diseases / Q000517:prevention & control*